Concepedia

Steffen Ballerstedt

SB

Statistics

Publications

4

Citations

144

H-Index

4

Active since

2016

Affiliations

Novartis (Switzerland)(Current)

Steffen Ballerstedt is an author at Novartis (Switzerland) specializing in drug approval processes, biostatistics, and clinical trials.

Publications per year

2016–2022

4

Publications

4

A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components

Gaohong Dong, Di Li, Steffen Ballerstedt et al. · Pharmaceutical Statistics · 2016 · 74 citations

Public Health, Biostatistics, Clinical Epidemiology +13

Predicting drug approvals: The Novartis data science and artificial intelligence challenge

Kien Wei Siah, Nicholas Kelley, Steffen Ballerstedt et al. · Patterns · 2021 · 36 citations · Full text

Computing, Data Science, Drug Approval Processes +7

Improving the assessment of the probability of success in late stage drug development

Lisa V. Hampson, Björn Bornkamp, Björn Holzhauer et al. · Pharmaceutical Statistics · 2021 · 20 citations

Pharmacy, Pharmaceutical Policy, Bayesian Data Analysis +16

Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study

Björn Holzhauer, Lisa V. Hampson, John Paul Gosling et al. · Pharmaceutical Statistics · 2022 · 14 citations · Full text

Natural Sciences, Biostatistics, Decision Sciences +14

1–4 of 4